Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Acrivon Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +2 vs. Q1 2026
- Shares held
- 21.4M
- +5.17M (+31.8%) vs. Q1 2026
- Total value
- $38.1M
- +$15.5M (+68.8%) vs. Q1 2026
- New holders
- 6
- 21 more added
- Sold out
- 4
- 9 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 30 | $0 | 0.00% | +5+20.0% | Added |
| Citigroup Inc | 6 | $11 | 0.00% | +6 | New |
| Caitong International Asset Management Co., Ltd | 50 | $89 | 0.00% | +46+1,150.0% | Added |
| SBI Securities Co., Ltd. | 75 | $134 | 0.00% | +1+1.4% | Added |
| Steward Partners Investment Advisory, LLC | 326 | $580 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 400 | $712 | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 481 | $856 | 0.00% | 00.0% | Unchanged |
| Redwood Park Advisors LLC | 500 | $890 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 537 | $956 | 0.00% | −97−15.3% | Reduced |
| Nisa Investment Advisors, LLC | 584 | $1.04K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 751 | $1.34K | 0.00% | +113+17.7% | Added |
| Crews Bank & Trust | 1,044 | $1.86K | 0.00% | +1,044 | New |
| Tower Research Capital LLC (TRC) | 1,677 | $2.98K | 0.00% | −2,849−62.9% | Reduced |
| Morgan Stanley | 5,233 | $9.31K | 0.00% | −31,438−85.7% | Reduced |
| FMR LLC | 6,957 | $12.4K | 0.00% | −2,465−26.2% | Reduced |
| Barclays PLC | 7,354 | $13.1K | 0.00% | +1,414+23.8% | Added |
| Federated Hermes, Inc. | 7,924 | $14.1K | 0.00% | 00.0% | Unchanged |
| Marex Group plc | 10,000 | $17.8K | 0.00% | −10,000−50.0% | Reduced |
| HRT Financial LP | 10,316 | $18.0K | 0.00% | +10,316 | New |
| AAFCPAs Wealth Management, LLC | 10,678 | $19.0K | 0.01% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 13,309 | $23.7K | 0.00% | −14,163−51.6% | Reduced |
| Goldman Sachs Group Inc | 14,920 | $26.6K | 0.00% | +178+1.2% | Added |
| Verdad Advisers, LP | 15,054 | $26.8K | 0.03% | +15,054 | New |
| Bank of America Corp | 16,407 | $29.2K | 0.00% | −106−0.6% | Reduced |
| Prelude Capital Management, LLC | 24,015 | $42.7K | 0.00% | 00.0% | Unchanged |
| Spark Investment Management LLC | 28,300 | $50.4K | 0.10% | +28,300 | New |
| Dimensional Fund Advisors LP | 29,332 | $52.2K | 0.00% | +10,968+59.7% | Added |
| Citadel Advisors LLC | 41,276 | $73.5K | 0.00% | +41,276 | New |
| UBS Group AG | 43,850 | $78.1K | 0.00% | +9,216+26.6% | Added |
| State Street Corp | 67,145 | $119.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 67,202 | $119.6K | 0.00% | +18,300+37.4% | Added |
| Jane Street Group, LLC | 74,648 | $132.9K | 0.00% | −165,043−68.9% | Reduced |
| XTX Topco Ltd | 178,239 | $317.3K | 0.00% | +111,357+166.5% | Added |
| Vanguard Fiduciary Trust Co | 184,128 | $327.7K | 0.00% | +76,599+71.2% | Added |
| Gsa Capital Partners LLP | 200,415 | $357.0K | 0.02% | +13,699+7.3% | Added |
| BlackRock, Inc. | 239,112 | $425.6K | 0.00% | +30,173+14.4% | Added |
| Geode Capital Management, LLC | 265,241 | $472.3K | 0.00% | +28,850+12.2% | Added |
| Bridgeway Capital Management, LLC | 378,900 | $674.4K | 0.01% | +220,000+138.5% | Added |
| Marshall Wace, LLP | 531,856 | $946.7K | 0.00% | −28,580−5.1% | Reduced |
| Two Sigma Investments, LP | 641,498 | $1.14M | 0.00% | +252,103+64.7% | Added |
| Renaissance Technologies LLC | 758,863 | $1.35M | 0.00% | +423+0.1% | Added |
| Wellington Management Group LLP | 888,130 | $1.58M | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 952,008 | $1.69M | 0.00% | +229,973+31.9% | Added |
| Acadian Asset Management LLC | 1,165,119 | $2.07M | 0.00% | +319,146+37.7% | Added |
| Sands Capital Ventures, LLC | 2,289,271 | $4.07M | 0.66% | +166,666+7.9% | Added |
| Ra Capital Management, L.P. | 12,229,396 | $21.8M | 0.19% | +3,888,888+46.6% | Added |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −33,814−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,679−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −4,453−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |